|
Case Name |
Date Filed |
Judge |
Drug |
Patent |
|
Pfizer Inc. v. Roxane Labs., Inc., 12-0593 (S.D. Ohio) |
July 3, 2012 |
Hon. Edmund A. Sargus |
Pristiq®(desvenlafaxine) |
6,673,838 |
|
Endo Pharma. Inc. v. TWI Pharma., Inc., 12-0848 (D. Del.) |
July 5, 2012 |
Hon. Gregory M. Sleet |
Lidoderm®Patch (lidocaine) |
5,741,510 6,096,334 5,827,529 |
|
Cubist Pharma., Inc. v. Hospira, Inc., 12-0859 (D. Del.) |
July 9, 2012 |
Hon. Gregory M. Sleet |
Cubicin®(daptomycin for injection) |
8,129,342 |
|
Shionogi, Inc. v. Nostrum Labs., Inc., 12-4402 (D.N.J.) |
July 13, 2012 |
Hon. Robert B. Kugler |
Fortamet®(metformin hydrochloride extended-release tablets) |
6,099,859 6,866,866 |
|
Novartis Pharma. Corp. v. Sun Pharma. Indus., Inc., 12-4393 (D.N.J.) |
July 14, 2012 |
Hon. Susan D. Wigenton |
Zometa®(zoledronic acid) Reclast®(zoledronic acid) |
7,932,241 |
|
Alcon Pharma. Ltd. v. Apotex Inc., 12-0960 (D. Del.) |
July 20, 2012 |
Hon. Sue L. Robinson |
Vigamox®(moxifloxacin hydrochloride ophthalmic solution) |
6,716,830 7,671,070
|
|
Novartis Pharma. Corp. v. Lupin Ltd., 12-4552 (D.N.J.) |
July 20, 2012 |
Hon. William J. Martini |
Diovan HCT®(valsartan / hydrochlorothiazide tablets) |
6,294,197 |
|
Celgene Corp. v. Natco Pharma. Ltd., 12-4571 (D.N.J.) |
July 20, 2012 |
Hon. Susan D. Wigenton |
Revlimid®(lenalidomide capsules) |
5,635,517 6,281,230 7,189,740 7,968,569 7,977,357 8,193,219 |
|
Purdue Pharma L.P. v. Actavis Elizabeth LLC, 12-5615 (S.D.N.Y.) |
July 20, 2012 |
Hon. Sidney H. Stein |
OxyContin®(oxycodone hydrochloride extended-release tablets) |
8,114,383 |
|
Alcon Pharma. Ltd. v. Lupin Ltd., 12-0973 (D. Del.) |
July 24, 2012 |
Hon. Sue L. Robinson |
Moxeza®(moxifloxacin hydrochloride ophthalmic solution) |
6,716,830 7,671,070
|
|
Sunovion Pharma. Inc. v. Watson Pharma., Inc., 12-0993 (D. Del.) |
July 27, 2012 |
Hon. Leonard P. Stark |
Xopenex HFA®(levalbuterol tartrate inhalation aerosol) |
7,256,310 |
|
Southern Research Institute v. Abon Pharma LLC, 12-4709 (D.N.J.) |
July 27, 2012 |
Hon. William J. Martini |
Clolar®(clofarabine injection) |
5,661,136 |
|
Meda Pharma. Inc. v. Cadila Healthcare Ltd., 12-4719 (D.N.J.) |
July 27, 2012 |
Hon. Michael A. Shipp |
Astepro®(azelastine 0.15 % nasal spray) |
8,071,073 |
|
Galderma Labs., L.P. v. Watson Pharma., Inc., 12-2563 (N.D. Tex.) |
July 27, 2012 |
Hon. Ed Kinkeade |
Epiduo®(adapalene / benzoyl peroxide gel) |
8,071,644 8,080,537 8,129,362 |
|
Millenium Pharma. Inc. v. Sandoz Inc., 12-1011 (D. Del.) |
Aug. 2, 2012 |
Hon. Gregory M. Sleet |
Velcade®(bortezomib injection) |
6,713,446 6,958,319 |
|
Astrazeneca Pharma. LP v. Amneal Pharma., LLC, 12-4841 (D.N.J.) |
Aug. 2, 2012 |
Hon. Joel A Pisano |
Seroquel XR®(quetiapine fumarate extended-release tablets) |
5,948,437 |
|
Nycomed Gmbh v. Apotex Inc., 12-1073 (S.D. Ind.) |
Aug. 2, 2012 |
Hon. Tanya W. Pratt |
Omnaris®(ciclesonide nasal spray) |
6,767,901 6,939,559 7,235,247 |
|
Cumberland Pharma. Inc. v. Perrigo Co., 12-6327 (N.D. Ill.) |
Aug. 9, 2012 |
Hon. Ruben Castillo |
Acetadote®(acetylcysteine intravenous) |
8,148,356 |
|
Janssen Pharma., Inc. v. Glenmark Generics Ltd., 12-5009 (D.N.J.) |
Aug. 9, 2012 |
Hon. Stanley R. Chessler |
Ortho Tri-Cyclen®LO (norgestimate / ethinyl estradiol) |
6,214,815 |
|
Luitpold Pharma., Inc. v. Amneal Pharma., LLC, 12-5064 (D.N.J.) |
Aug. 10, 2012 |
Hon. Joel A. Pisano |
Sprix®(ketorolac tromethamine nasal spray) |
6,333,044 |
|
Santarus, Inc. v. Dr. Reddy’s Labs. Inc., 12-5202 (D.N.J.) |
Aug. 15, 2012 |
Hon. Peter G. Sheridan |
Zegerid®(omeprazole / sodium bicarbonate capsules) |
6,699,885 6,489,346 6,645,988 7,399,772 |
|
Gilead Sciences, Inc. v. Lupin Ltd., 12-6293 (S.D.N.Y.) |
Aug. 16, 2012 |
Hon. Richard J. Sullivan |
Emtriva®(emtricitabine capsules) |
6,642,245 6,703,396 |
|
Merck Sharp & Dohme Corp. v. Watson Labs., Inc., 12-5228 (D.N.J.) |
Aug. 20, 2012 |
Hon. Freda L. Wolfson |
Propecia®(finasteride tablets) |
5,571,817 5,547,957 |
|
Gilead Sciences, Inc. v. Cipla Ltd., 12-6350 (S.D.N.Y.) |
Aug. 20, 2012 |
Hon. Richard J. Sullivan |
Emtriva®(emtricitabine capsules) |
6,642,245 6,703,396 |
|
Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.p.A. v. Actavis South Atlantic LLC, 12-1061 (D. Del.) |
Aug. 21, 2012 |
Hon. Leonard P. Stark |
Oleptro®(trazodone hydrochloride extended-release tablets) |
8,133,893 |
|
ViiV Healthcare Co. v. Mylan Inc., 12-1065 (D. Del.) |
Aug. 22, 2012 |
Hon. Richard G. Andrews |
Lexiva®(fosamprenavir calcium tablets) |
6,436,989 |
|
Purdue Pharma. Products L.P. v. Actavis Elizabeth LLC, 12-5311 (D.N.J.) |
Aug. 23, 2012 |
Hon. Jose L. Linares |
Intermezzo®(zolpidem tartrate tablets) |
7,682,628 |
|
Janssen Products, L.P. v. Lupin Ltd., 12-5358 (D.N.J.) |
Aug. 24, 2012 |
Hon. William H. Walls |
Prezista®(darunavir tablets) |
RE43,596 |
|
Purdue Pharma. Products L.P. v. Watson Pharma., Inc., 12-5390 (D.N.J.) |
Aug. 27, 2012 |
Hon. Jose L. Linares |
Intermezzo®(zolpidem tartrate tablets) |
7,682,628 |
|
Merck & Co., Inc. v. Sun Pharma. Indus., Ltd., 12-5374 (D.N.J.) |
Aug. 27, 2012 |
Hon. Freda L. Wolfson |
Ganirelix Acetate Injection |
5,757,082 6,653,286 |
|
Mallinckrodt, LLC v. Apotex Inc., 12-1087 |
Aug. 30, 2012 |
Hon. Mary Pat Thynge |
Pennsaid®(diclofenac sodium topical solution) |
8,217,078 |
|
AbbVie, Inc. v. Amneal Pharma., LLC, 12-1088 (D. Del.) |
Aug. 30, 2012 |
Hon. Sue L. Robinson |
Niaspan®(niacin extended-release tablets) |
6,080,428 |
|
GlaxoSmithKline LLC v. Apotex Inc., 12-1090 (D. Del.) |
Aug. 31, 2012 |
Hon. Richard G. Andrews |
Avodart®(dutasteride capsules) |
5,565,467 |
|
Medicis Pharma. Corp. v. Actavis Mid Atlantic LLC, 12-1091 (D. Del.) |
Aug. 31, 2012 |
Hon. Leonard P. Stark |
Zyclara®(imiquimod) Cream (3.75%) |
8,236,816 |
|
Teva Branded Pharma. Products R&D, Inc. v. Perrigo Pharma. Co., 12-1101 (D. Del.) |
Sept. 5, 2012 |
Hon. Gregory M. Sleet |
ProAir®HFA (albuterol sulfate) Inhalation Aerosol |
7,105,152 7,566,445 |
|
Novartis Pharma. Corp. v. Apotex Inc., 12-5574 (D.N.J.) |
Sept. 6, 2012 |
Hon. Jose L. Linares |
Lotrel®(amlodipine / benazepril hydrochloride capsules) |
6,162,802 |
|
Salix Pharma., Inc. v. Lupin Ltd., 12-1104 (D. Del.) |
Sept. 7, 2012 |
Hon. Gregory M. Sleet |
Apriso®(mesalamine extended-release capsules) |
6,551,620 |
|
Salix Pharma., Inc. v. Lupin Ltd., 12-2708 (D. Md.) |
Sept. 10, 2012 |
Hon. William D. Quarles, Jr. |
Apriso®(mesalamine extended-release capsules) |
6,551,620 |
|
Otsuka Pharma. Co., Ltd. v. Apotex Corp., 12-5645 (D.N.J.) |
Sept. 10, 2012 |
Hon. Mary L. Cooper |
Abilify®(aripiprazole oral solution) |
6,977,257 5,006,528 |
|
Upsher-Smith Labs., Inc. v. Auxilium Pharma., Inc., 12-5648 (D.N.J.) |
Sept. 10, 2012 |
Hon. Jose L. Linares |
Testim®1% (testosterone gel) |
7,608,605 7,608,606 7,608,607 7,608,608 7,608,609 7,608,610 7,935,690 8,063,029 |
|
Purdue Pharma. Products L.P. v. Novel Labs., Inc., 12-5650 (D.N.J.) |
Sept. 10, 2012 |
Hon. Jose L. Linares |
Intermezzo®(zolpidem tartrate tablets) |
7,682,628 |
|
Braintree Labs., Inc. v. Cypress Pharma., Inc., 12-6851 (S.D.N.Y.) |
Sept. 11, 2012 |
Hon. Alison J. Nathan |
Suprep®(sodium sulfate / potassium sulfate / magnesium sulfate oral solution) |
6,946,149 |
|
Avanir Pharma., Inc. v. Actavis South Atlantic, LLC, 12-1122 (D. Del.) |
Sept. 12, 2012 |
Hon. Leonard P. Stark |
Nuedexta®(dextromethorphan hydrobromide / quinidine sulfate capsules) |
8,227,484 |
|
Avanir Pharma., Inc. v. Par Pharma., Inc., 12-1123 (D. Del.) |
Sept. 12, 2012 |
Hon. Leonard P. Stark |
Nuedexta®(dextromethorphan hydrobromide / quinidine sulfate capsules) |
8,227,484 |
|
Avanir Pharma., Inc. v. Watson Pharma., Inc., 12-1124 (D. Del.) |
Sept. 12, 2012 |
Hon. Leonard P. Stark |
Nuedexta®(dextromethorphan hydrobromide / quinidine sulfate capsules) |
8,227,484 |
|
Avanir Pharma., Inc. v. Wockhardt Ltd., 12-1125 (D. Del.) |
Sept. 12, 2012 |
Hon. Leonard P. Stark |
Nuedexta®(dextromethorphan hydrobromide / quinidine sulfate capsules) |
8,227,484 |
|
Actelion Pharma. Ltd. v. Apotex Inc., 12-5743 (D.N.J.) |
Sept. 14, 2012 |
Hon. Noel L. Hillman |
Tracleer®(bosentan tablets) |
5,292,740 |
|
Otsuka Pharma. Co., Ltd. v. Silarx Pharma., Inc., 12-5809 (D.N.J.) |
Sept. 14, 2012 |
Hon. Mary L. Cooper |
Abilify®(aripiprazole oral solution) |
6,977,257 |
|
Cubist Pharma., Inc. v. Hospira, Inc., 12-1142 (D. Del.) |
Sept. 17, 2012 |
Hon. Gregory M. Sleet |
Cubicin®(daptomycin for injection) |
6,468,967 6,852,689 RE39,071 8,058,238 8,129,342 |
|
Merck Sharp & Dohme Corp. v. Sandoz Inc., 12-6077 (D.N.J.) |
Sept. 27, 2012 |
Hon. Jose L. Linares |
Zetia®(ezetimibe tablets) |
RE42,461 5,846,966 7,030,106 7,612,058 |
